{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:49:11Z","timestamp":1789786151675,"version":"4.0.1"},"reference-count":39,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"bioM\u00e9rieux Korea Co., Ltd. (Seoul, Republic of Korea)"},{"name":"GeneX Inc. (Seoul, Republic of Korea)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: Due to the extreme infectivity of SARS-CoV-2, sample-to-answer SARS-CoV-2 reverse transcription (RT) polymerase chain reaction (PCR) assays are urgently needed in order to facilitate infectious disease surveillance and control. The purpose of this study was to evaluate three sample-to-answer SARS-CoV-2 RT-PCR assays\u2014BioFire COVID-19 Test, BioFire RP 2.1, and Cepheid Xpert Xpress SARS-CoV-2\u2014using clinical samples. Methods: A total of 77 leftover nasopharyngeal swab (NP) swabs (36 positives and 41 negatives) confirmed by reference SARS-CoV-2 RT real-time (q) PCR assay were collected. The clinical sample concordance, as specified by their respective emergency use authorizations (EUAs), in comparison to the reference SARS-CoV-2 RT-qPCR assay, was assessed. Results: The results showed that all three sample-to-answer SARS-CoV-2 RT-PCR assays provided perfectly concordant results consistent with the reference SARS-CoV-2 RT-qPCR assay. The BioFire COVID-19 Test exhibited the best turnaround time (TAT) compared to the other assays, regardless of the test results, using one-way analysis of variance followed by Scheffe\u2019s post hoc test (p &lt; 0.001). The Xpert Xpress SARS-CoV-2 showed a shorter average TAT (mean \u00b1 standard deviation, 49.9 \u00b1 3.1 min) in the positive samples compared to that (55.7 \u00b1 2.5 min) of the negative samples. Conclusions: Our evaluation demonstrates that the BioFire COVID-19 Test, BioFire RP 2.1, and Cepheid Xpert Xpress SARS-CoV-2 assays compare favorably to the reference SARS-CoV-2 RT-qPCR assay, along with a 100% concordance in assay results for clinical samples and an acceptable analytical performance at their guaranteed limits of detection. The addition of a widely used simultaneous sample-to-answer SARS-CoV-2 RT-PCR assay will contribute to the number of medical laboratories able to test for COVID-19.<\/jats:p>","DOI":"10.3390\/genes14010233","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T06:03:30Z","timestamp":1673849010000},"page":"233","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Evaluation of BioFire COVID-19 Test, BioFire Respiratory Panel 2.1, and Cepheid Xpert Xpress SARS-CoV-2 Assays for Sample-to-Answer Detection of SARS-CoV-2"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7354-4234","authenticated-orcid":false,"given":"Joonhong","family":"Park","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju 54907, Republic of Korea"},{"name":"Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National Medical Center, Seoul 04564, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3211-8903","authenticated-orcid":false,"given":"Jaehyeon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju 54907, Republic of Korea"},{"name":"Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5700-9036","authenticated-orcid":false,"given":"Ki Ho","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e00796-20","DOI":"10.1128\/JCM.00796-20","article-title":"Understanding, Verifying, and Implementing Emergency Use Authorization Molecular Diagnostics for the Detection of SARS-CoV-2 RNA","volume":"58","author":"Mitchell","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_2","first-page":"341","article-title":"Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: A systematic review and meta-analysis","volume":"27","author":"Mazzaferri","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e24285","DOI":"10.1002\/jcla.24285","article-title":"Comparison of next generation diagnostic systems (NGDS) for the detection of SARS-CoV-2","volume":"36","author":"Sanchez","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104614","DOI":"10.1016\/j.jcv.2020.104614","article-title":"SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: Evaluation and utility","volume":"131","author":"Jokela","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e00783-20","DOI":"10.1128\/JCM.00783-20","article-title":"Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2","volume":"58","author":"Zhen","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"115260","DOI":"10.1016\/j.diagmicrobio.2020.115260","article-title":"Evaluation of the BioFire\u00ae COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples","volume":"99","author":"Eckbo","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"104426","DOI":"10.1016\/j.jcv.2020.104426","article-title":"Multi-center evaluation of cepheid xpert\u00ae xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic","volume":"128","author":"Wolters","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104538","DOI":"10.1016\/j.jcv.2020.104538","article-title":"Clinical evaluation of the BioFire\u00ae Respiratory Panel 2.1 and detection of SARS-CoV-2","volume":"129","author":"Creager","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.2147\/IDR.S328327","article-title":"Clinical Comparison of Three Sample-to-Answer Systems for Detecting SARS-CoV-2 in B.1.1.7 Lineage Emergence","volume":"14","author":"Jian","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100014","DOI":"10.1016\/j.jcvp.2021.100014","article-title":"Clinical evaluation of the GeneXpert\u00ae Xpert\u00ae Xpress SARS-CoV-2\/Flu\/RSV combination test","volume":"1","author":"Johnson","year":"2021","journal-title":"J. Clin. Virol. Plus"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jalm\/jfab086","article-title":"Comparison of 6 SARS-CoV-2 Molecular Methods and Correlation With the Cycle Threshold Distribution in Clinical Specimens","volume":"6","author":"Raju","year":"2021","journal-title":"J. Appl. Lab. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.cmi.2020.07.026","article-title":"Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection","volume":"26","author":"Liotti","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"113925","DOI":"10.1016\/j.jviromet.2020.113925","article-title":"Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay","volume":"284","author":"Goldenberger","year":"2020","journal-title":"J. Virol. Methods"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e02955-20","DOI":"10.1128\/JCM.02955-20","article-title":"Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2\/Flu\/RSV Test","volume":"59","author":"Mostafa","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.3346\/jkms.2021.36.e328","article-title":"Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A\/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs","volume":"36","author":"Yun","year":"2021","journal-title":"J. Korean Med. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3343\/alm.2020.40.5.351","article-title":"Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea","volume":"40","author":"Hong","year":"2020","journal-title":"Ann. Lab. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CMR.19.1.165-256.2006","article-title":"Real-time PCR in clinical microbiology: Applications for routine laboratory testing","volume":"19","author":"Espy","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Poritz, M.A., Blaschke, A.J., Byington, C.L., Meyers, L., Nilsson, K., Jones, D.E., Thatcher, S.A., Robbins, T., Lingenfelter, B., and Amiott, E. (2011). FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: Development and application to respiratory tract infection. PLoS ONE, 6.","DOI":"10.1371\/annotation\/468cfdcd-184c-42f7-a1d0-3b72a2f6a558"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"121392","DOI":"10.1016\/j.talanta.2020.121392","article-title":"Diagnostic techniques for COVID-19 and new developments","volume":"220","author":"Sheikhzadeh","year":"2020","journal-title":"Talanta"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3201\/eid2610.201955","article-title":"Pooling Upper Respiratory Specimens for Rapid Mass Screening of COVID-19 by Real-Time RT-PCR","volume":"26","author":"Kim","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Becker, M.G., Taylor, T., Kiazyk, S., Cabiles, D.R., Meyers, A.F.A., and Sandstrom, P.A. (2020). Recommendations for sample pooling on the Cepheid GeneXpert\u00ae system using the Cepheid Xpert\u00ae Xpress SARS-CoV-2 assay. PLoS ONE, 15.","DOI":"10.1101\/2020.05.14.097287"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"115238","DOI":"10.1016\/j.diagmicrobio.2020.115238","article-title":"Sample pooling on the Cepheid Xpert\u00ae Xpress SARS-CoV-2 assay","volume":"99","author":"Graham","year":"2021","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1038\/s41598-022-09039-6","article-title":"A four specimen-pooling scheme reliably detects SARS-CoV-2 and influenza viruses using the BioFire FilmArray Respiratory Panel 2.1","volume":"12","author":"Ranadheera","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00772-20","DOI":"10.1128\/JCM.00772-20","article-title":"Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays","volume":"58","author":"Moran","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e01136-20","DOI":"10.1128\/JCM.01136-20","article-title":"Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution","volume":"58","author":"Basu","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"104428","DOI":"10.1016\/j.jcv.2020.104428","article-title":"Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2","volume":"128","author":"Smithgall","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"104660","DOI":"10.1016\/j.jcv.2020.104660","article-title":"Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?","volume":"133","author":"Falasca","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijid.2020.12.088","article-title":"Low clinical performance of the Isopollo COVID-19 detection kit (M Monitor, South Korea) for RT-LAMP SARS-CoV-2 diagnosis: A call for action against low quality products for developing countries","volume":"104","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3343\/alm.2023.43.1.111","article-title":"Comparison of the Clinical Performance of the Point-of-care STANDARD M10 SARS-CoV-2 and Xpert Xpress SARS-CoV-2 Assays","volume":"43","author":"Hong","year":"2023","journal-title":"Ann. Lab. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pathol.2021.10.001","article-title":"Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: The need for an alternate interpretative criteria in a low prevalence setting","volume":"54","author":"Varadhan","year":"2022","journal-title":"Pathology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"104683","DOI":"10.1016\/j.jcv.2020.104683","article-title":"A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay","volume":"133","author":"Khoshchehreh","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1093\/cid\/ciaa638","article-title":"Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples","volume":"71","author":"Bullard","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Corman","year":"2020","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3343\/alm.2022.42.3.389","article-title":"Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay","volume":"42","author":"Hong","year":"2022","journal-title":"Ann. Lab. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2001650","DOI":"10.2807\/1560-7917.ES.2020.25.39.2001650","article-title":"SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene","volume":"25","author":"Ziegler","year":"2020","journal-title":"Eurosurveillance"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"115699","DOI":"10.1016\/j.diagmicrobio.2022.115699","article-title":"Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant","volume":"103","author":"Choi","year":"2022","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2021.06.001","article-title":"SARS-CoV-2 Mutations and their Viral Variants","volume":"63","author":"Cosar","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/diagnostics13010034","article-title":"Rapid Evaluation of the Xpert&reg; Xpress CoV-2 plus and Xpert&reg; Xpress CoV-2\/Flu\/RSV plus Tests","volume":"13","author":"Noble","year":"2023","journal-title":"Diagnostics"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/1\/233\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:07:25Z","timestamp":1760119645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/1\/233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["genes14010233"],"URL":"https:\/\/doi.org\/10.3390\/genes14010233","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]}}}